Jaundice & cholestatic liver diseases


Published on

Published in: Healthcare
  • Be the first to comment

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Jaundice & cholestatic liver diseases

  1. 1. ◘ Izatty Lim ◘ 0308188 ◘ 11 April 2014 ◘ Bilirubin Metabolism Cholestatis • Clinical Features • Lab findings • Morphology • Cholestatic liver disease Pathogenesis of Jaundice Causes of Jaundice
  2. 2.   Jaundice  yellow discoloration of skin & sclerae  systemic retention of bilirubin ( serum level above 2.0mg/dL)  Cholestasis  Impaired bile flow  systemic retention of not only bilirubin but also other solutes eliminated in bile ( bile salts & cholesterol) Introduction  2 major function of hepatic bile: o Constitutes the 1° pathway for elimination of bilirubin, excess cholesterol & xenobiotics o Secreted bile salts and phospholipid molecules promote emulsification of dietary fat
  3. 3.   Bilirubin  end product of heme degradation  Daily production  0.2 – 0.3g • Breakdown of senescent red cells within mononuclear phagocytes • Turnover of hepatic hemoproteins  Heme  Biliverdin  Bilirubin  Bilirubin formed outside the liver in cells of mononuclear phagocyte system is released & bound to serum albumin Bilirubin & Bile Acids Hepatocellular processing of bilirubin: 1) Carrier-mediated uptake at the sinusoidal membrane 2) Cytosolic protein binding and delivery to the endoplasmic reticulum 3) Conjugation with one or two molecules of glucuronic acid by bilirubin uridine diphosphate–glucuronosyltransferase 4) Excretion of the water-soluble, nontoxic bilirubin glucuronides into bile. • Most bilirubin glucuronides  deconjugated by gut bacterial β-glucuronidases & degraded to colorless urobilinogens. • Urobilinogens & the residue of intact pigment are largely excreted in feces. • ≈ 20% of the urobilinogens are reabsorbed in the ileum & colon  returned to liver  reexcreted into bile. • Conjugated & unconjugated bile acids also are reabsorbed in the ileum  returned to the liver by enterohepatic circulation.
  4. 4.  Bilirubin Metabolism & Elimination  (1) Normal bilirubin production (0.2 to 0.3 g/day) is derived primarily from the breakdown of senescent circulating red cells, with a minor contribution from degradation of tissue heme-containing proteins.  (2) Extrahepatic bilirubin is bound to serum albumin and delivered to the liver.  Hepatocellular uptake (3) and glucuronidation (4) by glucuronosyltransferase in the hepatocytes generate bilirubin monoglucuronides & diglucuronides, which are water-soluble and readily excreted into bile.  (5) Gut bacteria deconjugate the bilirubin and degrade it to colorless urobilinogens. The urobilinogens and the residue of intact pigments are excreted in the feces, with some reabsorption & reexcretion into bile.
  5. 5.   In the normal adult, • rate of systemic bilirubin production = rates of hepatic uptake, conjugation, and biliary excretion. • Equilibrium between bilirubin production and clearance disrupted Jaundice  More than one mechanism may operate to cause jaundice • Especially in hepatitis, when both unconjugated and conjugated bilirubin may be produced in excess. • In severe disease, bilirubin levels may reach 30 - 40 mg/dL.  Of these various causes of jaundice, • MC: hepatitis, obstruction to the flow of bile & hemolytic anemia. Pathogenesis
  6. 6.   Neonatal jaundice or physiologic jaundice of the newborn • almost every newborn develops transient & mild unconjugated hyperbilirubinemia • hepatic machinery for conjugating & excreting bilirubin does not fully mature until about 2 weeks of age  Jaundice also may result from inborn errors of metabolism • Gilbert syndrome, a relatively common (7% of the population), benign, somewhat heterogeneous inherited condition • Manifest as mild, fluctuating unconjugated hyperbilirubinemia. • Primary cause : ↓ hepatic levels of glucuronosyltransferase (mutation in the encoding gene) • Polymorphisms in the gene  variable expression of this disease. • not associated with any morbidity. • Dubin-Johnson syndrome • Result from autosomal recessive defect in the transport protein responsible for hepatocellular excretion of bilirubin glucuronides across the canalicular membrane. • Affected persons exhibit conjugated hyperbilirubinemia. • Other than having a darkly pigmented liver (from polymerized epinephrine metabolites, not bilirubin) and hepatomegaly, patients are otherwise without functional problems
  7. 7.  Main Causes of Jaundice
  8. 8.   Pathologic condition of impaired bile flow, leading to accumulation of bile pigment in the hepatic parenchyma  Can be caused by extrahepatic or intrahepatic obstruction of bile channels, or by defects in hepatocyte bile secretion • May manifest as jaundice • Sometimes pruritus • Skin xanthomas (focal accumulations of cholesterol) sometimes appear, the result of hyperlipidemia and impaired excretion of cholesterol. • Symptoms related to intestinal malabsorption, including nutritional deficiencies of the fat-soluble vitamins A, D, or K.  Pathogenesis remains obscure Cholestatis  A characteristic laboratory finding: • ↑ serum alkaline phosphatase (enzyme in bile duct epithelium & canalicular membrane of hepatocytes  reflects the detergent action of retained bile salts on hepatocyte membranes) • ↑ γ-glutamyl transpeptidase (GGT, canalicular ectoenzyme)  reflects the detergent action of bile salts retained in the luminal space of the bile canaliculus on the apical membranes of hepatocytes & bile duct epithelial cells
  9. 9.   depend on its severity, duration, and underlying cause  Common to both obstructive & non-obstructive cholestasis is the accumulation of bile pigment within the hepatic parenchyma  Elongated green-brown plugs of bile visible in dilated bile canaliculi Rupture of canaliculi bile extravasation phagocytosed by Kupffer cells.  Droplets of bile pigment also accumulate within hepatocytes  fine, foamy appearance (feathery degeneration). Morphology In the parenchyma (upper panel), Enlarged cholestatic hepatocytes (1) with dilated canalicular spaces (2). Apoptotic cells (3) Kupffer cells (4) with regurgitated bile pigments. In the portal tracts of obstructed liver (lower panel), bile ductular proliferation (5), edema, bile pigment retention (6), and eventually neutrophilic inflammation (not shown). Surrounding hepatocytes (7) are swollen & undergoing degeneration.
  10. 10.   Obstruction of the biliary tree  distention of upstream bile ducts and ductules by bile. • The bile stasis and backpressure  proliferation of the duct epithelial cells and looping & reduplication of ducts & ductules. • Unlike the extensive ductular reaction in the setting of massive hepatic necrosis, in obstruction, the ductular proliferation is confined to portal tracts. • The labyrinthine ductules reabsorb secreted bile salts, serving to protect the downstream obstructed bile ducts from the toxic detergent action of bile salts. • Associated histologic findings include portal tract edema and periductular infiltrates of neutrophils. Biliary Obstruction  Extrahepatic biliary obstruction frequently is amenable to surgical correction.  By contrast, cholestasis caused by diseases of the intrahepatic biliary tree  cannot be treated surgically (short of transplantation) • the patient's condition may be worsened by an operative procedure. • urgency in identifying the cause of jaundice and cholestasis.
  11. 11.   Primary biliary cirrhosis (PBC)  chronic inflammatory intrahepatic liver disorder that slowly destroys the small- to-medium-sized bile ducts.  When these ducts are damaged, bile builds up in the liver (cholestasis) and over time damages liver tissue.  Primary sclerosing cholangitis (PSC)  extrahepatic cholestatic liver disease (affecting the part of the bile duct that is outside of the liver) that damages the bile ducts both inside and outside of the liver.  In both diseases,  inflammation leads to progressive thickening, scarring, and destruction of the bile ducts.  The buildup of bile, bile salts, and cholesterol in the liver causes damage to cell membranes in the liver, reduced production of bile salts, and fibrosis (development of scar tissue).  Fibrosis is both a marker of liver damage and a potential contributor to liver failure. Continuing damage causes scarring or cirrhosis (the liver slowly deteriorates and malfunctions), and prevents proper liver function and impaired blood circulation in the intestines. Cholestatic liver diseases
  12. 12.
  13. 13.   Robbins Basic Pathology 9th Edition • By Kumar, Abbas, Aster  Robbins and Cotran’s Pathologic Basis of Disease Seventh Edition • By Kumar, Abbas, Fausto References
  14. 14.  The end. Thank You!